A Biologically Effective Dose of > 105 Gy is Associated with Improved Overall Survival in Stage I Non-Small Cell Lung Cancer Patients Treated with Stereotactic Body Radiation Therapy

Authors

Stahl JM, Ross R, Harder EM, Mancini BR, Soulos PR, Dosoretz AP, Finkelstein S, Shafman TD, Husain ZA, Evans SB, Yu JB, Gross CP, Decker RH

Disease (cancer type)

Lung

Presentation Type

Poster

Conference

ASTRO

Year

09/25/2016

21st Century Oncology Physicians

Back
To top